Caribou Biosciences Correlations
CRBU Stock | USD 1.00 0.00 0.00% |
The current 90-days correlation between Caribou Biosciences and Editas Medicine is 0.35 (i.e., Weak diversification). The correlation of Caribou Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Caribou Biosciences Correlation With Market
Modest diversification
The correlation between Caribou Biosciences and DJI is 0.26 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Caribou |
Moving together with Caribou Stock
0.83 | EYEN | Eyenovia | PairCorr |
0.73 | MOLN | Molecular Partners | PairCorr |
0.71 | SNDL | SNDL Inc | PairCorr |
0.91 | CLDX | Celldex Therapeutics | PairCorr |
0.88 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.75 | CRVS | Corvus Pharmaceuticals | PairCorr |
0.69 | GKOS | Glaukos Corp | PairCorr |
0.73 | LIVN | LivaNova PLC | PairCorr |
0.92 | MODD | Modular Medical | PairCorr |
0.9 | APYX | Apyx Medical | PairCorr |
0.85 | SGHT | Sight Sciences | PairCorr |
0.92 | SRDX | SurModics | PairCorr |
0.78 | CNMD | CONMED | PairCorr |
Moving against Caribou Stock
0.85 | FNA | Paragon 28 | PairCorr |
0.82 | CMRX | Chimerix Sell-off Trend | PairCorr |
0.79 | CPIX | Cumberland Pharmaceuticals | PairCorr |
0.86 | NVRO | Nevro Corp | PairCorr |
0.79 | LUCD | Lucid Diagnostics Buyout Trend | PairCorr |
0.66 | NYXH | Nyxoah | PairCorr |
0.6 | LUNG | Pulmonx Corp | PairCorr |
0.54 | INMD | InMode | PairCorr |
0.4 | KIDS | Orthopediatrics Corp | PairCorr |
0.88 | BRK-A | Berkshire Hathaway | PairCorr |
0.88 | BRK-B | Berkshire Hathaway | PairCorr |
0.78 | FWEDF | Fireweed Zinc | PairCorr |
0.74 | TOI | Oncology Institute Earnings Call This Week | PairCorr |
0.68 | NHNCF | NAVER Corp | PairCorr |
0.53 | TRGGF | Tarachi Gold Corp | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Caribou Stock performing well and Caribou Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Caribou Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
NTLA | 3.68 | (0.41) | 0.00 | (0.34) | 0.00 | 7.76 | 20.66 | |||
EDIT | 6.85 | 0.45 | 0.03 | 0.05 | 8.87 | 12.20 | 119.53 | |||
CRSP | 2.69 | (0.07) | 0.00 | (0.14) | 0.00 | 5.26 | 19.32 | |||
VERV | 4.57 | 0.19 | 0.02 | 0.03 | 5.10 | 11.11 | 30.05 | |||
BEAM | 3.41 | (0.12) | 0.00 | (0.17) | 0.00 | 7.58 | 23.04 | |||
FATE | 4.80 | (0.99) | 0.00 | (0.56) | 0.00 | 9.29 | 22.21 | |||
PRME | 4.59 | (0.31) | 0.00 | (0.18) | 0.00 | 10.03 | 25.37 | |||
SANA | 7.71 | 1.40 | 0.17 | 0.46 | 6.56 | 10.15 | 178.30 | |||
ADPT | 3.61 | 0.55 | 0.13 | 0.16 | 3.36 | 12.29 | 27.21 |
Caribou Biosciences Corporate Management
Sriram MBA | Chief Officer | Profile | |
Amy CFA | Vice Communications | Profile | |
Cindy Hayashi | VP HR | Profile | |
Ryan Fischesser | Interim Controller | Profile | |
Jason MBA | Chief Officer | Profile | |
JD Esq | Chief Secretary | Profile | |
Timothy MBA | Chief Officer | Profile |